Get the Stockscreener App
4.93
0.40%
-0.02
After Hours:
4.93
Lifecore Biomedical Inc stock is traded at $4.93, with a volume of 60,793.
It is down -0.40% in the last 24 hours and up +12.56% over the past month.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that offers differentiated capabilities in the development, filling, and finishing of complex sterile injectable pharmaceutical products in syringes and vials. It manufactures injectable-grade Hyaluronic Acid. Lifecore recognizes revenue in two different product categories, CDMO and fermentation.
See More
Previous Close:
$4.95
Open:
$4.97
24h Volume:
60,793
Relative Volume:
0.23
Market Cap:
$151.21M
Revenue:
$135.28M
Net Income/Loss:
$-99.56M
P/E Ratio:
-1.4849
EPS:
-3.32
Net Cash Flow:
$-38.92M
1W Performance:
+0.82%
1M Performance:
+12.56%
6M Performance:
-7.16%
1Y Performance:
-34.66%
1-Day Range:
$4.8001
$5.02
1-Week Range:
$4.6008
$5.02
52-Week Range:
$3.6793
$8.90
Lifecore Biomedical Inc Stock (LFCR) Company Profile
Name
Lifecore Biomedical Inc
Sector
Phone
(952) 368-4300
Address
3515 LYMAN BOULEVARD, CHASKA
Lifecore Biomedical Inc Stock (LFCR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-20-23 | Downgrade | Stephens | Overweight → Equal-Weight |
Lifecore Biomedical Inc Stock (LFCR) Latest News
FINAL DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Lifecore - AccessWire
LFCR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Lifecore Biomedical, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - GlobeNewswire Inc.
LFCR Investors Have Opportunity to Lead Lifecore Biomedical, Inc. Securities Fraud Lawsuit with the Schall Law Firm - Business Wire
LFCR DEADLINE TOMORROW: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Lifecore Biomedical, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important September 27 Deadline in Securities Class Action – LFCR - GlobeNewswire Inc.
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Lifecore Biomedical, Inc. (LFCR) - Business Wire
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Lifecore - GlobeNewswire
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Lifecore - GlobeNewswire Inc.
Lifecore Biomedical to Participate at Upcoming Industry Conferences and Events - GlobeNewswire
Lifecore Biomedical to Participate at Upcoming Industry Conferences and Events - StockTitan
DEADLINE ALERT for LFCR, OM, SAGE, and SMCI: The Law - GlobeNewswire
LFCR Shareholders Have Opportunity to Lead Lifecore Biomedical, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - AccessWire
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Lifecore Biomedical, Inc. of Class Action Lawsuit and Upcoming DeadlinesLFCR - PR Newswire
LFCR Investors Have Opportunity to Lead Lifecore Biomedical, Inc. Securities Fraud Lawsuit with the Schall Law Firm - Morningstar
Lifecore Biomedical announces board changes, sets meeting date - Investing.com India
Glancy Prongay & Murray LLP Reminds Investors of Looming - GlobeNewswire
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Lifecore Biomedical, Inc. (LFCR) - GlobeNewswire Inc.
272 Capital LP Has $120,000 Stake in Lifecore Biomedical, Inc. (NASDAQ:LFCR) - MarketBeat
Lifecore Biomedical announces board changes, sets meeting date By Investing.com - Investing.com Australia
Lifecore Biomedical announces board changes, sets meeting date - Investing.com
LFCR FINAL DEADLINE: ROSEN, LEADING TRIAL ATTORNEYS, - GlobeNewswire
LFCR FINAL DEADLINE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Lifecore Biomedical, Inc. Investors to Secure Counsel Before Important September 27 Deadline in Securities Class Action – LFCR - GlobeNewswire Inc.
LFCR SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Lifecore Biomedical, Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit! - AccessWire
Lifecore Biomedical Board Changes Ahead of Annual Meeting - TipRanks
Life360 (NASDAQ:LIF) Shares Up 4.3% - MarketBeat
Lifecore Biomedical, Inc. Investors: Please contact the Portnoy Law Firm to recover your ... - The Bakersfield Californian
Lifecore Biomedical, Inc. Investors: Please contact the - GlobeNewswire
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Lifecore - PR Newswire
LifeMD Inc (LFMD) Becoming More Attractive for Investors - Knox Daily
Why Liveperson Inc Stock Might Make Sense If Bought Today - Stocks Register
Bragar Eagel & Squire, P.C. Reminds Investors That Class - GlobeNewswire
LFCR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
LFCR Deadline: LFCR Investors Have Opportunity to Lead Lifecore Biomedical, Inc. Securities Fraud Lawsuit - Morningstar
LFCR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Lifecore Biomedical, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit! - AccessWire
Life Healthcare Group (OTCMKTS:LTGHY) Stock Price Up 1.1% - Defense World
Kayne Anderson Rudnick Investment Management LLC Grows Position in LCI Industries (NYSE:LCII) - Defense World
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Lifecore - AccessWire
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Lifecore - Stockhouse Publishing
LFCR Investors Have Opportunity to Lead Lifecore Biomedical, Inc. Securities Fraud Lawsuit - PR Newswire
LFCR DEADLINE NOTICE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Lifecore Biomedical, Inc. Investors to Secure Counsel Before Important September 27 Deadline in Securities Class Action – LFCR - ForexTV.com
LFCR DEADLINE NOTICE: ROSEN, SKILLED INVESTOR COUNSEL, - GlobeNewswire
LFCR SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Lifecore Biomedical, Inc. Investors Have Opportunity to Lead Class Action Lawsuit! - AccessWire
LFCRLifecore Biomedical, Inc. Latest Stock News & Market Updates - StockTitan
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Lifecore - GlobeNewswire
LFCR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Lifecore Biomedical, Inc. Investors Have Opportunity to Lead Class Action Lawsuit! - AccessWire
Lifecore Biomedical Expands Capacity With New Isolator Filler - Contract Pharma
Lifecore Biomedical Announces High-Speed, Multi-Purpose 5-Head Isolator Filler is GMP-Ready and Operational - GlobeNewswire
Lifecore Biomedical Announces High-Speed, Multi-Purpose 5-Head Isolator Filler is GMP-Ready and Operational - StockTitan
LFCR SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Lifecore Biomedical, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit! - AccessWire
Deadline coming up on Sept. 27th in Lawsuit for Investors who lost - openPR
LFCR Deadline: LFCR Investors Have Opportunity to Lead Lifecore Biomedical, Inc. Securities Fraud Lawsuit - PR Newswire
Faruqi & Faruqi Reminds Lifecore Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 27, 2024LFCR - PR Newswire
Lifecore Biomedical Inc Stock (LFCR) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.23%
0.18%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):